Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Travere Therapeutics, Inc. (TVTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Travere Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TVTX alertsNaomi Eichenbaum is recorded as Head of Investor Relations at Travere Therapeutics, Inc. (TVTX). Naomi Eichenbaum has spoken on 4 earnings calls across 1 company, most recently for Travere Therapeutics, Inc. on November 7, 2023. Travere Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Travere Therapeutics, Inc. includes Bradley Campbell (CEO and Board Member), Bradley L. Campbell (CEO and Board Member), Christopher Cline (CFO) and 7 others.
“Good afternoon, and welcome to Travere Therapeutics third quarter 2023 financial results and corporate update call. Thank you all for joining. Today's call will be led by our Chief Executive Officer, Dr. Eric Dube.”
“Good afternoon, and welcome to Travere Therapeutics second quarter 2023 financial results and corporate update call. Thank you all for joining us. Today's call will be led by our Chief Executive Officer, Dr. Eric Dube.”
“And welcome to Travere Therapeutics first quarter 2023 financial results and corporate update call. Today's call will be led by our Chief Executive Officer, Dr. Eric Dube.”
“Good afternoon, and welcome to Travere Therapeutics' Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Call. Thank you all for joining us.”
Biotechnology · Healthcare
Head of Investor Relations